Skip to main content
TipRanks
Go Ultimate75% OFF

Kane Biotech (KNE) Ownership - Who Owns Kane Biotech?

2 Followers

Kane Biotech (KNE) Ownership Overview

  • 34.33% Insiders
  • 65.67% Public Companies and Individual Investors

The ownership structure of Kane Biotech (TSE:KNE) stock is a mix of institutional, retail, and individual investors. , 34.33% is owned by Insiders, and 65.67% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
May 28, 2026Philip R RenaudC$1,000,000
Dec 18, 2025Philip R RenaudC$700,000

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

TSE:KNE top shareholders
Holder# of SharesType% HoldingValue
Philip R Renaud70,389,711Insider34.33%1,478,184

FAQ

What percentage of Kane Biotech (TSE:KNE) stock is held by retail investors?
According to the latest TipRanks data, approximately 65.67% of Kane Biotech (TSE:KNE) stock is held by public companies and individual investors.
Who owns the most shares of Kane Biotech (TSE:KNE)?
Philip R Renaud owns the most shares of Kane Biotech (TSE:KNE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.